Evidence map›Paper›PMID 35977101›Full record

ArticleBlood2023

Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma.

Jamie E Flerlage, Jason R Myers, Jamie L Maciaszek, Ninad Oak, Sara R Rashkin, Yawei Hui, Yong-Dong Wang, Wenan Chen, Gang Wu, Ti-Cheng Chang and 19 more

Open access · greenAbstract read
In one paragraph

Article in Blood, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Deep Learning in Hematology: From Molecules to Patients.Clinical hematology international · 2024
    Review
  6. Article
  7. HemaSphere · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 5 institutions in 2 countries.

Jamie E FlerlageDepartment of Oncology, St. Jude Children's Research Hospital and the University of Tennessee Health Sciences Center, Memphis, TN.
Jason R MyersCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-0341-0860
Jamie L MaciaszekDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Ninad OakDepartment of Oncology, St. Jude Children's Research Hospital and the University of Tennessee Health Sciences Center, Memphis, TN.ORCID 0000-0002-9806-0217
Sara R RashkinCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0001-5542-6891
Yawei HuiCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0001-6397-3086
Yong-Dong WangDepartment of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0001-8751-9216
Wenan ChenCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.
Gang WuCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-1678-5864
Ti-Cheng ChangCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.
Kayla HamiltonDepartment of Oncology, St. Jude Children's Research Hospital and the University of Tennessee Health Sciences Center, Memphis, TN.
Saima S TithiCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.
Lynn R GoldinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Melissa RotunnoDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Neil CaporasoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Aurélie VogtLeidos Biomedical, Inc, Frederick, MD.
Deborah FlamishWestat, Inc, Rockville, MD.
Kathleen WyattLeidos Biomedical, Inc, Frederick, MD.
Jia LiuLeidos Biomedical, Inc, Frederick, MD.
Margaret TuckerDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.ORCID 0000-0003-0274-6773
Christopher N HahnDepartment of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
Anna L BrownDepartment of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
Hamish S ScottDepartment of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
Charles MullighanDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-1871-1850
Kim E NicholsDepartment of Oncology, St. Jude Children's Research Hospital and the University of Tennessee Health Sciences Center, Memphis, TN.ORCID 0000-0002-5581-6555
Monika L MetzgerDepartment of Oncology, St. Jude Children's Research Hospital and the University of Tennessee Health Sciences Center, Memphis, TN.ORCID 0000-0002-7102-4611
Mary L McMasterDepartment of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-2208-9320
Jun J YangDepartment of Oncology, St. Jude Children's Research Hospital and the University of Tennessee Health Sciences Center, Memphis, TN.ORCID 0000-0002-0770-9659
Evadnie RampersaudCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN.
St. Jude Children's Research Hospital · USNational Institutes of Health · USLeidos (United States) · USSouth Australia Pathology · AUWestat (United States) · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Shondra Michelle Miller · 1985 to 2026
$166.9M
Family Studies ZIACP004410 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$56.1M
The Genetic Study of Families with a High Frequency of Hematopoietic MalignancyR03HD104066 · NICHD · UNIVERSITY OF ROCHESTER · PI FLERLAGE, JAMIE ELIZABETH · 2021 to 2022
$338k
NCI NIH HHS P30 CA021765NICHD NIH HHS R03 HD104066
6 · The paper itself

Abstract

Familial aggregation of Hodgkin lymphoma (HL) has been demonstrated in large population studies, pointing to genetic predisposition to this hematological malignancy. To understand the genetic variants associated with the development of HL, we performed whole genome sequencing on 234 individuals with and without HL from 36 pedigrees that had 2 or more first-degree relatives with HL. Our pedigree selection criteria also required at least 1 affected individual aged <21 years, with the median age at diagnosis of 21.98 years (3-55 years). Family-based segregation analysis was performed for the identification of coding and noncoding variants using linkage and filtering approaches. Using our tiered variant prioritization algorithm, we identified 44 HL-risk variants in 28 pedigrees, of which 33 are coding and 11 are noncoding. The top 4 recurrent risk variants are a coding variant in KDR (rs56302315), a 5' untranslated region variant in KLHDC8B (rs387906223), a noncoding variant in an intron of PAX5 (rs147081110), and another noncoding variant in an intron of GATA3 (rs3824666). A newly identified splice variant in KDR (c.3849-2A>C) was observed for 1 pedigree, and high-confidence stop-gain variants affecting IRF7 (p.W238∗) and EEF2KMT (p.K116∗) were also observed. Multiple truncating variants in POLR1E were found in 3 independent pedigrees as well. Whereas KDR and KLHDC8B have previously been reported, PAX5, GATA3, IRF7, EEF2KMT, and POLR1E represent novel observations. Although there may be environmental factors influencing lymphomagenesis, we observed segregation of candidate germline variants likely to predispose HL in most of the pedigrees studied.

Indexed as

Hodgkin DiseaseAdultCell Cycle ProteinsCodon, NonsenseGenetic Predisposition to DiseaseGerm-Line MutationHumansPedigreeWhole Genome SequencingYoung AdultCell Cycle ProteinsCodon, NonsenseKLHDC8B protein, human

Identifiers

PMID35977101
PMCPMC10082357
OpenAlexW4292133588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.